Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 19
1993 31
1994 58
1995 118
1996 133
1997 144
1998 163
1999 204
2000 254
2001 266
2002 297
2003 342
2004 379
2005 467
2006 421
2007 398
2008 507
2009 654
2010 677
2011 637
2012 709
2013 726
2014 790
2015 778
2016 858
2017 811
2018 768
2019 371
2020 20
Text availability
Article attribute
Article type
Publication date

Search Results

10,946 results
Results by year
Filters applied: . Clear all
Page 1
Proton pump inhibitors: use and misuse in the clinical setting.
Savarino V, et al. Expert Rev Clin Pharmacol 2018 - Review. PMID 30295105
The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly improved our therapeutic approach to acid-related diseases for their efficacy and safety. ...
The introduction of proton pump inhibitors (PPIs) into clinical practice has greatly improved our therapeutic approach …
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Moayyedi P, et al. Gastroenterology 2019 - Clinical Trial. PMID 31152740
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the short term, but long-term treatment was associated with adverse events in observational studies. ...
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are …
Proton Pump Inhibitors: What the Internist Needs to Know.
Spechler SJ. Med Clin North Am 2019 - Review. PMID 30466666
This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory effects of PPIs that are independent of their acid-suppressive effects. ...
This report reviews the physiology of gastric acid suppression by proton pump inhibitors (PPIs) and anti-inflammatory e …
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified.
Bruno G, et al. World J Gastroenterol 2019 - Review. PMID 31235994 Free PMC article.
Proton pump inhibitors (PPIs) are common medications within the practice of gastroenterology. These drugs, which act through the irreversible inhibition of the hydrogen/potassium pump (H+/K+-ATPase pump) in the gastric parietal cells, are used in the treatment of several acid-related disorders. ...
Proton pump inhibitors (PPIs) are common medications within the practice of gastroenterology. These drugs, which act th
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.
Xie Y, et al. BMJ 2019. PMID 31147311 Free PMC article.
OBJECTIVE: To estimate all cause mortality and cause specific mortality among patients taking proton pump inhibitors (PPIs). ...
OBJECTIVE: To estimate all cause mortality and cause specific mortality among patients taking proton pump inhibitors (P …
Adverse effects of proton pump inhibitors: fact or fake news?
Schubert ML. Curr Opin Gastroenterol 2018 - Review. PMID 30102612
PURPOSE OF REVIEW: The present review summarizes the past year's literature, both clinical and basic science, regarding potential adverse effects of proton pump inhibitors. ...SUMMARY: Most of the recent highly publicized serious adverse effects ascribed to proton pump inhibitors are not based on demonstrable evidence. ...
PURPOSE OF REVIEW: The present review summarizes the past year's literature, both clinical and basic science, regarding potential adverse ef …
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
Ray WA, et al. JAMA 2018. PMID 30512099 Free PMC article.
IMPORTANCE: Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication of oral anticoagulant treatment. ...
IMPORTANCE: Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the risk of upper gastrointestinal tra …
Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved.
Thong BKS, et al. Int J Environ Res Public Health 2019 - Review. PMID 31060319 Free PMC article.
The number of patients with gastroesophageal problems taking proton pump inhibitors (PPIs) is increasing. Several studies suggested a possible association between PPIs and fracture risk, especially hip fractures, but the relationship remains contentious. ...
The number of patients with gastroesophageal problems taking proton pump inhibitors (PPIs) is increasing. Several studi …
Proton pump inhibitors, adverse events and increased risk of mortality.
Lanas-Gimeno A, et al. Expert Opin Drug Saf 2019 - Review. PMID 31498687
Introduction: Proton pump inhibitors (PPIs) are among the most commonly prescribed drugs worldwide. However, concerns are growing about the serious adverse events and mortality linked to their long-term use. ...
Introduction: Proton pump inhibitors (PPIs) are among the most commonly prescribed drugs worldwide. However, concerns a …
Proton Pump Inhibitors in Kidney Disease.
Lazarus B and Grams ME. Clin J Am Soc Nephrol 2018. PMID 30262671 Free PMC article.
10,946 results
Jump to page
Feedback